Question explored with the scientific record
Conversation so far
- 1 What are the side effects of long term Benadryl usage?
- 2 What are the strongest human studies on dementia risk from daily Benadryl?
Answered on this page ↓
What are the strongest human studies on dementia risk from daily Benadryl?
The strongest human study on daily Benadryl and dementia risk is the 2025 Swedish nationwide case-control study of nearly 400,000 people.
That study found a clear dose-response relationship [1]. People who took strong anticholinergics like diphenhydramine for 1 to 3 years (365–1094 daily doses) had about 57% higher odds of dementia. Those who took them for 3 years or more (≥1095 daily doses) had about 66% higher odds [1]. The association was strongest for vascular dementia and Lewy body dementia, not Alzheimer's [1]. The researchers used 1-, 3-, and 5-year lag times to reduce the chance that people were taking the drug for early dementia symptoms, and the effect persisted [1].
A 2020 meta-analysis of 6 studies covering over 645,000 people found a pooled 46% higher risk of dementia after at least 3 months of anticholinergic use [2]. That analysis noted some publication bias and heterogeneity, meaning the true effect could be smaller or larger [2].
The mechanism is straightforward. Diphenhydramine is strongly anticholinergic—it blocks acetylcholine, a neurotransmitter essential for memory and learning. Chronic blockade of this system is biologically plausible to accelerate cognitive decline. The 2025 study specifically named antihistamines as one of the drug classes showing a dose-response association with dementia [1].
| Exposure level (cumulative DDDs) | Odds ratio for dementia | 95% confidence interval |
|---|---|---|
| 1–89 DDDs (low) | 1.10 | 1.08–1.12 |
| 90–364 DDDs (moderate) | 1.42 | 1.39–1.46 |
| 365–1094 DDDs (high, ~1–3 years) | 1.57 | 1.50–1.65 |
| ≥1095 DDDs (very high, 3+ years) | 1.66 | 1.55–1.79 |
These are observational studies, not randomized trials. People who take daily anticholinergics may differ from those who do not in ways that also affect dementia risk. But the dose-response gradient, the persistence after lag-time adjustments, and the biological mechanism all point to a real effect.
My call: daily Benadryl use for a year or more is associated with a 40–66% higher odds of developing dementia, with stronger links to vascular and Lewy body types. The evidence is observational but consistent and dose-dependent. Confidence: moderate—the association is robust across large studies, but causation cannot be proven without a randomized trial that will likely never be run.
Sources used 2
-
Anticholinergic burden and incident dementia: a Swedish nationwide case-control study
This Swedish nationwide case-control study investigates how cumulative anticholinergic burden, stratified by potency and drug class, relates to incident dementia and its subtypes, revealing a dose-dependent increase in risk with strong anticholinergics (especially urinary antisp…
DOI: 10.1186/s13195-025-01883-8 -
Increased risk of incident dementia following use of anticholinergic agents: A systematic literature review and meta‐analysis
This systematic review and meta-analysis evaluates whether ≥3 months of exposure to anticholinergic agents increases the risk of incident dementia in adults, finding a pooled approximate 46% higher risk, driven largely by bladder antimuscarinics, with higher risk at greater expo…
DOI: 10.1002/nau.24536